Search
for
Sort by
Research 361–390 of 1000+
- The Polycystic Ovary Syndrome - Challenges and Opportunities in Adolescent Medicine
- Skin manifestations of hyperandrogenism: an update
- An assessment of curcumin, curcumin spanlastics nanoparticles, and curcumin nanocrystals as possible drug delivery systems with antimicrobial, antioxidant, and antitumor activities
- The modern scientific interpretation of ancient wisdom: a review of the phytochemistry and pharmacology of Erzhi Pill and its constituent botanical drugs
- A Comprehensive Review of Management of Patients with Infertility having Polycystic Ovarian Syndrome
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Novel drugs of United States Food and Drug Administration approved in 2024
- The orchestrated network of skin photoaging: From intercellular crosstalk to molecular signaling
- Platelet Concentrates in Regenerative Medicine: A Comparative Review of Platelet-Rich Plasma, Platelet-Rich Fibrin, and Concentrated Growth Factors
- Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology
- Geriatric Dermatologic Therapy
- Ca <sup>2+</sup> -mediated protein citrullination regulates proliferation in the regenerating and malignant CNS
- Phytochemicals as Modulators of Human Endocrine Function: Bridging Traditional Remedies and Hormonal Health
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Farmácia dos Clérigos - Porto e nos Serviços Farmacêuticos da University College Hospital - Londres, Reino Unido, ao abrigo do programa Erasmus+
- Autologous Platelet Concentrates in Periodontology : Science, Concept, Protocols and Clinical Applications
- Polycystic Ovary Syndrome-Associated Acne: The Interplay of Hyperandrogenism, Insulin Resistance, and Therapeutic Strategies
- Effects of Selenium and Other Micronutrient Intake on Human Health
- Journal of Population Therapeutics and Clinical Pharmacology
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Dehydrogenase, Cortisol, Dopamine, Zinc, and Vitamin D3 in Iraqi Patients with Polycystic Ovary Syndrome
- Understanding Polycystic Ovary Syndrome
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- Hair Loss in a Hemodialysis Patient after Repetitive Use of the Antipruritic Drug Nalfurafine: Implications of Impaired Angiogenesis for Hair Loss
- Das weiße Hautfettgewebe initiiert die IL-33-abhängige Expression von Interleukin 4/13 in myeloischen Zellen während einer Entzündung
- Androgen excess: a hallmark of polycystic ovary syndrome
- Modern Approaches to Treatment of Alopecia X in Dogs: Review of Research
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Molecular Mechanisms Affecting Development of Animal Fibers and Some Studies on Goats
- Platelet-Rich Plasma Contains High Concentrations of DKK1, A Potent Inhibitor of Wnt Signaling that Limits Bone Regeneration and Hair Growth